诚意药业：关于帕拉米韦注射液获得药品注册证书的公告

Group 1 - The core point of the article is that Chengyi Pharmaceutical has received the drug registration certificate for Palavivirin injection from the National Medical Products Administration [2] Group 2 - The approval of the drug registration certificate indicates a significant regulatory milestone for the company [2] - This development may enhance the company's product portfolio and market competitiveness in the pharmaceutical industry [2] - The news reflects the ongoing efforts of the company to expand its offerings in response to market demands [2]